The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
|
---|---|
Published in |
Frontiers in oncology, April 2022
|
DOI | 10.3389/fonc.2022.872531 |
Pubmed ID | |
Authors |
Ji Wang, Chao Chen, Lu Wang, Mingjun Xie, Xinyang Ge, Sufan Wu, Yong He, Xiaozhou Mou, Chenyang Ye, Yi Sun |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Hong Kong | 1 | 33% |
Switzerland | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 47 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 13% |
Student > Bachelor | 4 | 9% |
Student > Master | 4 | 9% |
Student > Ph. D. Student | 3 | 6% |
Student > Doctoral Student | 2 | 4% |
Other | 5 | 11% |
Unknown | 23 | 49% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 9 | 19% |
Medicine and Dentistry | 4 | 9% |
Immunology and Microbiology | 3 | 6% |
Agricultural and Biological Sciences | 2 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Other | 3 | 6% |
Unknown | 25 | 53% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2023.
All research outputs
#2,282,286
of 26,737,936 outputs
Outputs from Frontiers in oncology
#514
of 23,602 outputs
Outputs of similar age
#51,124
of 456,752 outputs
Outputs of similar age from Frontiers in oncology
#28
of 1,537 outputs
Altmetric has tracked 26,737,936 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 23,602 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 1,537 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.